Natriutetic peptides inhibit endothelin-1 and angiotensin-II mediated human coronary smooth muscle cell proliferation  by Wei, Chi-Ming & Burnett, John C.
JACC February 1996 ABSTRACTS- Poster 217A 
analysis. Unear regression models were developed to predict In(VO2max) 
from 6MW with and without 8SA, age, and sex. 
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Inclusion of BSA and age significantly improved the model (In[VO2max] 
in mYmin = 4.569 + 0.0026 (6MW) + 0.838 BSA - 0.0036 Age; r = 0,902). 
In conclusion, use of this regression model may, if validated, allow accurate 
prediction of VO2 max from 6MW. 
~ Arachldonic Ac id- Induced Dilation of  Eplcardlal 
coronary  Artery Is Maintained in Awake Dogs 
With Chronic Exerc ise Training Plus Rapid 
Cardiac Pacing 
Gang-Hua Yi, Daniel Burkhaff, Mathtas Knecht, Suili Pop,skis, 
Milton Packer, Jie Wang. Columbia Univ. College of P&S, New York, NY 
Previous studies has shown that arachidonie acid(AA)-induced dilation of 
epicardial coronary artery (CA) is attenuated but PGI2-induced dilation of CA 
is preserved in heart failure (CHF), suggesting that the attenuated response 
of AA is due to defective endothelial conversion of AA to prostacyclins. Since 
exercise training (EX) normalizes some aspects of endothelial function, the 
objective of this study was to determine whether EX improves AA-Inducad 
dilation of CA during development of CHR Dogs(n = 6) were chronically 
instrumented for measurements of left ventricular and aortic pressure, coro- 
nary blood flow and diameter of CA and for chronic cardiac pacing. Dogs 
were cardiac paced for 4 wks and treadmill EX (4.4 -;- 0.36 kin/hour) was 
performed on a treadmill 2 hours/day throughout this 4 wks. Changes in CA 
diameter induced by AA were examined before (Control) and after this 4 wk 
period (Pacing plus exercise). The results are as follows: 
Baseline Response ~ % & 
Centre! 
AA 250 #g/kg 3.50 ± 0.26 3.63 ± 0.25 0.14 ± 0.03" 4.15 ± 1.10" 
AA 500 pg/kg 3.50 ± 0.26 3.68 ± 0.26 0.18 ± 0.05* 5.23 ± 1.57 ° 
After 4 wk pacing plus exercise 
AA 250 #g/kg 3.81 ± 0.21 3.93 ± 0.20 0.13 ~ 0.02" ~..',7 ~- 0.74* 
AA 500 ~g/kg 3.79 ± 0.22 3.96 ± 0.22 0.17 ~ 0.02* 4.52 -..+. 0,76* 
values are CA diameter in ram. "p < 0.05 from baseline 
This contrasts with previous results showing that the response of CA 
diameter to AA is eliminated in dogs with the same pacing regimen but 
without exercise. Thus, EX training protected endotheliurrdprostaglandin- 
mediated dilation of CA dudng development of CHR This may indicate that 
the conversion of AA to prostacyclins was normalized by EX. 
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~ Natdu~et;~, Inhibit ~ndothelin-1 and Popl ldcs  
Anglotensln-l l  Mediated Human Coronary Smooth  
Muscle Cell Prol l ferat lon 
Chi-Ming Wet, John C. Bumett, Jr.. Mayo Clinic, Rochester, MN 
Atrial natrluretie pep"de (ANP), brain natriuretlc pap,de (BNP) and C-type 
natriuretie pep"de (CNP) are a family of structurally related paptldes that 
participate in the integrated control of renal and cardiovascular funotlon via 
activation of particulate guanylyl cyciase and generation of cGMP. While an 
antimitogenic action for the natriuretic pep"des have been investigated in 
non-human mammalian cells, the antiprellferatlve ncllon of the naMuretic 
peptides in human coronary vascular smooth muscle ceils (HCVSMC) pro- 
llferatlon remain undefined. Therefore, the current study was designed to 
investigate the inhibitory function of ANP, BNP and CNP upon endothelin- 
I (ET-1) and anglotensin II (All) mediated HCVSMC pmliteration. Cultured 
HCSMC were stimulated by ET-t (10 -7 M) and All (10 -7 M) with and without 
ANP.BNP and CNP (10 -~ M each) and thymidine incorporation determined. 
These studies were repeated with HS-142-1 (10 -s M), an antagonist of the 
na~urotie pep"de guanylyl cydase linked receptors. (cpnVwell) 
Control ET-1 ET-1 + HS All All + HS 
Baseline 190±24 1362±288§ 929-4-186§ 
ANP 420 ± 133" 630 ± 278 t 161 ± 33" 882 ± 251 ~" 
BNP 240±61" 766 -;- 2231' 156-I-26- 813±2381 
CNP 296±51" 1233 ±589t 153±30" 592± 200t 
§p < 0.05 vs control; *p < O.O5 vs baseline; tp < 0.05 va ET arid All. 
These data suggest: (1) ET-1 and All are potent stimulators for human 
coronary vascular smooth muscle cells proliferation. (2) ANP, BNP and CNP 
are potent inhibitors for ET and All media',ed human coronary smooth muscle 
cell proliferation. (3) These inhibitory actions of ANP, BNP and CNP are 
mediated by guanylyl cycl~..e linked natduretic peptide receptors 
~ Interact ion o f  Endothelin-1 With Vasodi lators:  
Effects on Myocardial  Contracti l i ty and Myocardial  
Energy Metabol ism 
Martin E. Bayer, G0nther $1esak, Silks Kazmaier, Stefan Nerz, Uwe Helber, 
Hans Martin Hoffmeister. Mad/ca/Hospital, Dept. ill, University of TObingen, 
Germany 
In contrast o in vitro experiments, which demonstrated a positive inotropy of 
endothalin-1 (ET-1), in viva studies could not detect such a positive inotropy. 
It was supposed that the direct positive inotropy of ET-1 is counterbalanced in 
viva by an indirect cardio-depreasant effect due to its vasoconstrictive effect 
with consequent myocardial ischemia. If this hypothesis is true the positive 
inoIropy of ET-1 Should be unmasked by coronary vasedilating drugs. 
We examined in open-chest rats whether adenosine (ADO: 2.0 mg,~g/min) 
or mcisidomine (MOL: 5.0 mg/kg) can unmask this positive inotropy of 1.0 
nmol/kg ET-1 i. v. by preventing myocardial ischemia. Besides measure- 
ments in the intact circulation isovelumic measurements (isovol. LVSP, iso- 
voL dP/dtmax) were performed for quantification of myocardial contraclJlity. 
Additionally myocardial high-energy phosphates were determined (energy 
charge : [ATP + 1/2AOPIAATP + ADP + AMP] as index of ischemia). 
ET-1 ADO ÷ ET-1 M'IL + ET-I NaCI 
Isevol. LVSP [%] 104±2 113±2" 108±2" 97±2 
IsevoL dP/dtmax [%] 98:1:3 120+3" 115±5" 100±2 
TPR ~a] 286±21 ° 236±27" 269 ±27* 96±3 
ATP ~moVgww] 3A±0.1" 3.8±0.1 4.3±0.3 4.1-;-0.1 
Energy charge [%1 73±3 ° 85±2 80±2 84±2 
Means :1: SEM; nemodynamics in% of pminfusion values, "p < 0.01. 
Conclusions: Adenosine and melsidomina antagonize the ET-induced 
vasoconstriction in pert and can unmask the positive inotropy of ET-1 by 
preventing ET-induced myocardial ischemia. 
~ Sustained Tissue Nitric Oxide Release Af ter  Local 
Delivery o f  a Novel Nitric Oxide Donor  
David S. Marks, Vincent J. Pomp"i, Myung H. Jecng, Whyte G. Owen, 
Zvonimir S. Katusic, David R. Holmes, Jr., Robert $. Schwartz. 
Cardiovascular Disease and Special Hematology, Mayo Clinic, Rochester, 
MN 
Nitric oxide (NO) is a potent vasodilator and platelet inhibitor. The tecal 
delivery of small-molecular weight NO-dehOrn has been associated with 
marked biologic elfects extending beyond the short holf-lite of these com- 
pounds. To examine the NO elaborated by vessels exposed to local de- 
livery of NO-donors, we administered a spontaneous NO-donating com- 
pound, Dansylpiperezine nonoate (GLO/NO) (1--2 raM) intraluminally to de- 
endothelialized porcine carotid arteries ex-vivo, rinsed the vessel free of the 
agent, and assayed for nitrite predu~on fluoromalrtcally two houm after local 
delivery. Nitrite in the supemalast after local delivery of GLO/NO was ele- 
vated (771.4-133 nM/gm tissue) compared to de-endothelielized control (438 
+ 68; p = 0.002) and to local delivery of the vehicle (385 ::t: 34; p = 0.008), 
GLO/NO treated vessels exhibited marked displaceabie NO elaboration after 
exposure to HgCI2, compared to vehicle (320.4-148 vs. 370.4- 69; p = 0.001) 
demonstrating substantial tissue thidl nitrcsation by this agent. 
Cone/us/on: Local administration of low molecular weight NO-denors re- 
sults in marked NO elaboration after treatment. These observations suggest 
tissue bound NO promotes the prolonged biologic effects after local delivery 
of NO-donors and suggests a potential therapy to mitigate adverse events 
after vascular injury. 
